CLUE: a randomized comparative effectiveness trial of IV nicardipine versus labetalol use in the emergency department
Abstract Introduction Our purpose was to compare the safety and efficacy of food and drug administration (FDA) recommended dosing of IV nicardipine versus IV labetalol for the management of acute hypertension. Methods Multicenter randomized clinical trial. Eligible patients had 2 systolic blood pres...
Uloženo v:
Hlavní autoři: | W. Frank Peacock, Joseph Varón, Brigitte M. Baumann, Pierre Borczuk, Chad Cannon, Abhinav Chandra, David Cline, Deborah B. Diercks, Brian Hiestand, Amy P. Hsu, P. Jois-Bilowich, Brian Kaminski, Philip Levy, Richard M. Nowak, Jon W. Schrock |
---|---|
Médium: | Artigo |
Jazyk: | angličtina |
Vydáno: |
2011
|
On-line přístup: | https://doi.org/10.1186/cc10289 https://ccforum.biomedcentral.com/counter/pdf/10.1186/cc10289 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
Podobné jednotky
-
CLUE: a randomized comparative effectiveness trial of IV nicardipine versus labetalol use in the emergency department
Autor: Peacock, W Frank, a další
Vydáno: (2011) -
Intravenous nicardipine and labetalol use in hypertensive patients with signs or symptoms suggestive of end-organ damage in the emergency department: a subgroup analysis of the CLUE trial
Autor: Cannon, Chad M, a další
Vydáno: (2013) -
Intracranial effects of nicardipine
Autor: Gaab, M. R., a další
Vydáno: (1985) -
Erythromelalgia induced by nicardipine.
Autor: Drenth, J. P.
Vydáno: (1989) -
Erythromelalgia induced by nicardipine.
Autor: Levesque, H., a další
Vydáno: (1989)